Insider holders · CIK 0001419600
Flexion Therapeutics Inc · FLXN
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| A/S Novo10% Owner | 2,133,131 | — | 2,133,131 | Jun 22, 2015 · 6:22 pm EDT | Form 4 |
| Sofinnova Partners SAS10% Owner | 2,095,491 | — | 2,095,491 | Jan 22, 2015 · 2:02 pm EST | Form 4 |
| Neil BodickChief Scientific Officer | 100,782 | 388,683 | 489,465 | Mar 5, 2019 · 4:26 pm EST | Form 4 |
| Michael D. ClaymanPresident and CEO | 70,856 | 388,683 | 459,539 | Mar 13, 2019 · 4:11 pm EDT | Form 4 |
| Samuel D ColellaDirector | 25,504 | 388,683 | 414,187 | Jun 6, 2017 · 6:49 pm EDT | Form 4 |
| Versant Development Fund III, L.P.10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| Robin L. Praeger10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:40 pm EDT | Form 4 |
| Versant Ventures III, LLC10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| Versant Venture Capital III, L.P.10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| Versant Side Fund III, L.P.10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| Charles M Warden10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:40 pm EDT | Form 4 |
| Bradley J Bolzon Ph.D.10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:40 pm EDT | Form 4 |
| Donald B Milder10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| Barbara N Lubash10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:40 pm EDT | Form 4 |
| Brian G Atwood10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| William J Link Ph.D.10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| Rebecca B Robertson10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| Ross A Jaffe M.D.10% Owner | — | 388,683 | 388,683 | Jun 10, 2016 · 9:16 pm EDT | Form 4 |
| David ArkowitzChief Financial Officer | 85,172 | — | 85,172 | Mar 5, 2019 · 4:27 pm EST | Form 4 |
| Christina WillwerthChief Strategy Officer | 58,419 | — | 58,419 | Mar 5, 2019 · 4:30 pm EST | Form 4 |
| Scott KelleyChief Medical Officer | 51,271 | — | 51,271 | Mar 5, 2019 · 5:32 pm EST | Form 4 |
| Mark S. LevineGeneral Counsel | 45,060 | — | 45,060 | Mar 5, 2019 · 4:29 pm EST | Form 4 |
| Kerry WentworthChief Regulatory Officer | 14,876 | 6,000 | 20,876 | Mar 5, 2019 · 8:17 pm EST | Form 4/A |
| Yamo DenizChief Medical Officer | 9,000 | — | 9,000 | Sep 15, 2017 · 5:12 pm EDT | Form 4 |
| Frederick W DriscollChief Financial Officer | 7,777 | — | 7,777 | Mar 24, 2017 · 4:24 pm EDT | Form 4 |
| C Ann MerrifieldDirector | 2,000 | — | 2,000 | Jun 16, 2016 · 5:59 pm EDT | Form 4 |
| Mark StejbachDirector | — | 1,580 | 1,580 | Jun 20, 2017 · 4:24 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.